Overdose Deaths Demand a New Paradigm for Opioid Rotation

Pain Medicine

Volumn 13, Issue 4, 2012, Pages 571-574

  Webster, Lynn R ^a   Fine, Perry G ^b  

^a Lifetree Clinical Research   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Equianalgesic Dose Tables; Opioid Dose Conversion; Opioid Rotation

Indexed keywords

GABAPENTIN; HYDROMORPHONE; OXYCODONE; PARACETAMOL; TRAZODONE;

ADULT; ARTICLE; CASE REPORT; DRUG FATALITY; DRUG OVERDOSE; HUMAN; MALE; RATING SCALE; VERBAL ANALOG SCALE;

EID: 84859769397     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2012.01356.x     Document Type: Article

References (14)

1. Mercadante S, Bruera E. Opioid switching: A systematic and critical review. Cancer Treat Rev 2006;32:304-15.
2. Mercadante S, Ferrera P, Villari P, etal. Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit. J Pain Symptom Manage 2009;37:632-41.
3. Bohnert AS, Valenstein M, Bair MJ, etal. Association between opioid prescribing patterns and opioid overdose-related deaths. J Am Med Assoc 2011;305:1315-21.
4. Dhalla IA, Mamdani MM, Sivilotti ML, etal. Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. CMAJ 2009;181:891-6.
5. Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf 2006;15:618-27.
6. Moore TJ, Cohen MR, Furberg CD. Serious adverse drug events reported to the Food and Drug Administration, 1998-2005. Arch Intern Med 2007;167:1752-9.
7. American Pain Foundation, Pain Safe Program. Frequently asked questions about opioid safety. 2011. Available at: (accessed March 1, 2012).
8. Webster LR, Cochella S, Dasgupta ND, etal. An analysis of the root causes for opioid-related overdose deaths in the United States. Pain Med 2011;12:S26-35.
9. Webster LR, Fine PG. Review and critique of opioid rotation practices and associated risks of toxicity. Pain Med 2012; DOI: 10.1111/j.1526-4637.2012.01357.x.
10. Lynch ME. A review of the use of methadone for the treatment of chronic non-cancer pain. Pain Res Manag 2005;10:133-44.
11. Fredheim OM, Kaasa S, Dale O, etal. Opioid switching from oral slow release morphine to oral methadone may improve pain control in chronic non-malignant pain: A nine-month follow-up study. Palliat Med 2006;20:35-41.
12. Oneschuk D, Bruera E. Respiratory depression during methadone rotation in a patient with advanced cancer. J Palliat Care 2000;16:50-4.
13. Watanabe S, Belzile M, Kuehn N, Hanson J, Bruera E. Capsules and suppositories of methadone for patients on high-dose opioids for cancer pain: Clinical and economic considerations. Cancer Treat Rev 1996;22(suppl A):131-6.
14. Webster LR, Brewer R, Morris D, Cleveland JM, Setnik B. Opioid titration and conversion in patients receiving morphine sulfate and naltrexone hydrochloride extended release capsules. Postgrad Med 2011;123:155-64.